共 21 条
- [21] DISEASE CONTROL RATE AT 9 AND 18 WEEKS AS PRIMARY ENDPOINTS FOR PHASE II CLINICAL TRIALS IN PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA: AN INDIVIDUAL PATIENT DATA COMBINED ANALYSIS OF 10 EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER (EORTC) LUNG CANCER GROUP STUDIES. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S406 - S407